4//SEC Filing
MORGAN PHILIP W 4
Accession 0000898432-04-000918
CIK 0001180253other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 7:46 PM ET
Size
9.4 KB
Accession
0000898432-04-000918
Insider Transaction Report
Form 4
MORGAN PHILIP W
Director10% Owner
Transactions
- Purchase
Common Stock Warrant (Right to Purchase)
2004-11-04+34,320→ 34,320 total(indirect: See)Exercise: $6.00From: 2004-11-04Exp: 2009-11-04→ Common Stock (34,320 underlying) - Purchase
Common Stock
2004-11-04$3.00/sh+104,000$312,000→ 2,104,000 total(indirect: See)
Footnotes (3)
- [F1]Includes 1,125,000 shares already held, and 58,500 shares acquired in the reported transaction by The Global Life Science Ventures Funds II GmbH & Co. KG, and 875,000 shares already held, and 45,500 shares acquired in the reported transaction by The Global Life Science Ventures Fund II, L.P. Mr. Morgan, a director of the issuer, is (i) a director of Global Life Science (GP) Limited, general partner of The Global Life Science Ventures Fund II, L.P. and (ii) a member of the Managing Board of The GSLV Special Partner, GmbH & Co. KG, special partner of The Global Life Science Ventures Funds II, GmbH & Co. KG. Mr. Morgan disclaims beneficial ownership of all shares issued or issuable to the foregoing entities, except to the extent of his proportionate pecuniary interest, but exercises shared voting and investment power with respect to some of these shares.
- [F2]The warrants were issued in connection with a private financing. No value was attributed to the warrants in the financing, and none can be determined at this time.
- [F3]Includes warrants to purchase 19,305 shares acquired in the reported transaction by The Global Life Science Ventures Funds II GmbH & Co. KG, and warrants to purchase 15,015 shares acquired in the reported transaction by The Global Life Science Ventures Fund II, L.P. Mr. Morgan, a director of the issuer, is (i) a director of Global Life Science (GP) Limited, general partner of The Global Life Science Ventures Fund II, L.P. and (ii) a member of the Managing Board of The GSLV Special Partner, GmbH & Co. KG, special partner of The Global Life Science Ventures Funds II, GmbH & Co. KG. Mr. Morgan disclaims beneficial ownership of all shares issued or issuable to the foregoing entities, except to the extent of his proportionate pecuniary interest, but may exercise shared voting and investment power with respect to some of these warrant shares upon exercise.
Documents
Issuer
Cyberkinetics Neurotechnology Systems, Inc.
CIK 0001180253
Entity typeother
Related Parties
1- filerCIK 0001306151
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 7:46 PM ET
- Size
- 9.4 KB